Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 76,912 | 63,868 | 53,853 | 56,886 | 55,877 |
| Cost of Goods | 43,741 | 46,290 | 40,535 | 43,606 | 43,916 |
| Gross Profit | 33,171 | 17,578 | 13,318 | 13,280 | 11,961 |
| Operating Expenses | 19,541 | 21,616 | 24,113 | 21,147 | 19,902 |
| Operating Income | 14,371 | -3,748 | -10,260 | -7,261 | -7,025 |
| Interest Expense | 204 | 232 | 210 | 341 | -551 |
| Other Income | -3,829 | -296 | 241 | 1,405 | 657 |
| Pre-tax Income | 10,338 | -4,276 | -10,229 | -6,197 | -5,817 |
| Income Tax | 2,805 | -1,268 | -3,582 | -5,532 | -3,296 |
| Net Income Continuous | 7,533 | -3,008 | -6,647 | -665 | -2,521 |
| Net Income | $7,533 | $-3,008 | $-6,647 | $-665 | $-2,521 |
| EPS Basic Total Ops | 0.17 | -0.07 | -0.15 | -0.01 | -0.06 |
| EPS Basic Continuous Ops | 0.17 | -0.07 | -0.15 | -0.01 | -0.06 |
| EPS Diluted Total Ops | 0.17 | -0.07 | -0.15 | -0.01 | -0.06 |
| EPS Diluted Continuous Ops | 0.17 | -0.07 | -0.15 | -0.01 | -0.06 |
| EBITDA(a) | $17,649 | $-385 | $-6,901 | $-4,009 | $-3,249 |